Stay updated on GA 40 mg Injection vs Placebo in RRMS - Clinical Trial
Sign up to get notified when there's something new on the GA 40 mg Injection vs Placebo in RRMS - Clinical Trial page.

Latest updates to the GA 40 mg Injection vs Placebo in RRMS - Clinical Trial page
- CheckyesterdayChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.5%
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check23 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, and API users can provide input before this change. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference0.8%
- Check51 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.0%
- Check65 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study information regarding the efficacy of Glatiramer Acetate for treating relapsing-remitting multiple sclerosis, while a new revision number has been added.SummaryDifference14%
- Check73 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
Stay in the know with updates to GA 40 mg Injection vs Placebo in RRMS - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GA 40 mg Injection vs Placebo in RRMS - Clinical Trial page.